Cushing's syndrome laboratory findings: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Cushing's syndrome}} {{CMG}} ==Overview== ==Laboratory Findings== When Cushing's is suspected, either a dexamethasone suppression test (administration of d...")
 
Line 8: Line 8:


==Laboratory Findings==
==Laboratory Findings==
When Cushing's is suspected, either a [[dexamethasone suppression test]] (administration of dexamethasone and frequent determination of cortisol and ACTH level), or a 24-hour urinary measurement for cortisol offer equal detection rates.<ref>Raff H, Findling JW. ''A physiologic approach to diagnosis of the Cushing's syndrome.'' Ann Intern Med 2003;138:980-91. PMID 12809455</ref> Dexamethasone is a [[glucocorticoid]] and simulates the effects of cortisol, including [[negative feedback]] on the [[pituitary gland]]. When dexamethasone is administered and a blood sample is tested, high cortisol would be indicative of Cushing's syndrome because there is an ectopic source of cortisol or ACTH (eg: adrenal adenoma) that is not inhibited by the dexamethasone. A novel approach, recently cleared by the US FDA, is sampling cortisol in [[saliva]] over 24 hours, which may be equally sensitive, as late night levels of salivary cortisol are high in Cushingoid patients. Other pituitary hormone levels may need to be ascertained.  Performing a [[physical examination]] to determine any [[visual field]] defect may be necessary if a pituitary lesion is suspected, which may compress the [[optic chiasm]] causing typical bitemporal hemianopia.
When Cushing's is suspected, either a [[dexamethasone suppression test]] (administration of dexamethasone and frequent determination of cortisol and ACTH level), or a 24-hour urinary measurement for cortisol offer equal detection rates.<ref>Raff H, Findling JW. ''A physiologic approach to diagnosis of the Cushing's syndrome.'' Ann Intern Med 2003;138:980-91. PMID 12809455</ref> Dexamethasone is a [[glucocorticoid]] and simulates the effects of cortisol, including [[negative feedback]] on the [[pituitary gland]]. When dexamethasone is administered and a blood sample is tested, high cortisol would be indicative of Cushing's syndrome because there is an ectopic source of cortisol or ACTH (eg: adrenal adenoma) that is not inhibited by the dexamethasone. A novel approach, recently cleared by the US FDA, is sampling cortisol in [[saliva]] over 24 hours, which may be equally sensitive, as late night levels of salivary cortisol are high in Cushingoid patients. Other pituitary hormone levels may need to be ascertained.  Performing a [[physical examination]] to determine any [[visual field]] defect may be necessary if a pituitary lesion is suspected, which may compress the [[optic chiasm]] causing typical bitemporal hemianopia.
 
When any of these tests are positive, [[CT scan]]ning of the adrenal gland and [[MRI]] of the [[pituitary gland]] are performed to detect the presence of any adrenal or pituitary [[adenoma]]s or [[incidentaloma]]s (the incidental discovery of harmless lesions). [[Scintigraphy]] of the adrenal gland with iodocholesterol scan is occasionally necessary. Very rarely, determining the cortisol levels in various veins in the body by venous catheterisation, working towards the pituitary (petrosal sinus sampling) is necessary.


==References==
==References==

Revision as of 20:57, 23 August 2012

Cushing's syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cushing's syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cushing's syndrome laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cushing's syndrome laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cushing's syndrome laboratory findings

CDC on Cushing's syndrome laboratory findings

Cushing's syndrome laboratory findings in the news

Blogs on Cushing's syndrome laboratory findings

Directions to Hospitals Treating Cushing's syndrome

Risk calculators and risk factors for Cushing's syndrome laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Laboratory Findings

When Cushing's is suspected, either a dexamethasone suppression test (administration of dexamethasone and frequent determination of cortisol and ACTH level), or a 24-hour urinary measurement for cortisol offer equal detection rates.[1] Dexamethasone is a glucocorticoid and simulates the effects of cortisol, including negative feedback on the pituitary gland. When dexamethasone is administered and a blood sample is tested, high cortisol would be indicative of Cushing's syndrome because there is an ectopic source of cortisol or ACTH (eg: adrenal adenoma) that is not inhibited by the dexamethasone. A novel approach, recently cleared by the US FDA, is sampling cortisol in saliva over 24 hours, which may be equally sensitive, as late night levels of salivary cortisol are high in Cushingoid patients. Other pituitary hormone levels may need to be ascertained. Performing a physical examination to determine any visual field defect may be necessary if a pituitary lesion is suspected, which may compress the optic chiasm causing typical bitemporal hemianopia.

References

  1. Raff H, Findling JW. A physiologic approach to diagnosis of the Cushing's syndrome. Ann Intern Med 2003;138:980-91. PMID 12809455


Template:WH Template:WS